Literature DB >> 22086673

Anti-inflammatory and anti-nociceptive effects of the ethanolic extracts of Alkanna frigida and Alkanna orientalis.

H Monsef Esfahani1, Z Navvab Esfahani, N Khosravi Dehaghi, A Hosseini-Sharifabad, K Tabrizian, M Parsa, Seyed Nasser Ostad.   

Abstract

Alkanna species are used in Iranian traditional medicine for treatment of rheumatoid arthritis and other inflammatory diseases. This study was designed to evaluate the anti-inflammatory and anti-nociceptive effects of Alkanna frigida and Alkanna orientalis ethanolic extracts via the carrageenan-induced paw edema test and formalin test in rat and mouse, respectively. Ethanolic extracts of plant root were prepared and were injected intraperitoneally 60 min before carrageenan-induced inflammation or formalin-induced nociception at 100, 200 and 400 mg/kg. Anti-inflammatory effects of plants were monitored for 3 h after carrageenan injection and anti-nociceptive effects were evaluated during the first hour after formalin injection. Diclofenac, a well-known anti-inflammatory and anti-nociceptive agent, was used as a positive control. Our results show that, in contrast to Alkanna orientalis, ethanolic extract of Alkanna frigida significantly decreases carrageenan-induced inflammation at 400 mg/kg, especially 3 h after inflammation induction. Both Alkanna frigida and Alkanna orientalis ethanolic extracts possess a remarkable anti-nociceptive effect at each dose (100, 200 and 400 mg/kg) in a dose-dependent manner during the first hour after formalin injection.The present findings provide more evidence for the potential anti-nociceptive effect of Alkanna sp. and the anti-inflammatory effect of Alkanna frigida. It supports their traditional indication in the treatment of pain and inflammatory-related diseases. These useful effects may result from the inhibitory interaction of the plant ethanolic extract with cyclooxygenase-2 enzyme and the subsequent reduction in prostaglandin production.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22086673     DOI: 10.1007/s11418-011-0603-1

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  13 in total

Review 1.  Cyclooxygenase-2: a therapeutic target.

Authors:  Marco E Turini; Raymond N DuBois
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

Review 2.  Arachidonic acid metabolism.

Authors:  P Needleman; J Turk; B A Jakschik; A R Morrison; J B Lefkowith
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

3.  Post-training cyclooxygenase-2 (COX-2) inhibition impairs memory consolidation.

Authors:  Lisa A Teather; Mark G Packard; Nicolas G Bazan
Journal:  Learn Mem       Date:  2002 Jan-Feb       Impact factor: 2.460

4.  The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats.

Authors:  David Dubuisson; Stephen G Dennis
Journal:  Pain       Date:  1977-12       Impact factor: 6.961

5.  The formalin test in mice: effect of formalin concentration.

Authors:  Jan Henrik Rosland; Arne Tjølsen; Bjørn Mæhle; Kjell Hole
Journal:  Pain       Date:  1990-08       Impact factor: 6.961

6.  Modified formalin test: characteristic biphasic pain response.

Authors:  Manabu Shibata; Tsuyako Ohkubo; Hiroshi Takahashi; Reizo Inoki
Journal:  Pain       Date:  1989-09       Impact factor: 6.961

7.  Comparison of relative antioxidant activities of British medicinal plant species in vitro.

Authors:  D Mantle; F Eddeb; A T Pickering
Journal:  J Ethnopharmacol       Date:  2000-09       Impact factor: 4.360

8.  The formalin test in mice: dissociation between inflammatory and non-inflammatory pain.

Authors:  Steinar Hunskaar; Kjell Hole
Journal:  Pain       Date:  1987-07       Impact factor: 6.961

9.  Dissociation between antinociceptive and anti-inflammatory effects of acetylsalicylic acid and indomethacin in the formalin test.

Authors:  Steinar Hunskaar; Odd-Geir Berge; Kjell Hole
Journal:  Pain       Date:  1986-04       Impact factor: 6.961

10.  Role of oxygen radicals and arachidonic acid metabolites in the reverse passive Arthus reaction and carrageenin paw oedema in the rat.

Authors:  N K Boughton-Smith; A M Deakin; R L Follenfant; B J Whittle; L G Garland
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

View more
  3 in total

1.  In vitro activity of Alkanna frigida extracts in comparison with glucantime against Leishmania major.

Authors:  Fariba Jafari; Abbasali Nourian; Asghar Fazaeli; Alireza Yazdinezhad; Ali Haniloo
Journal:  Iran J Microbiol       Date:  2013-06

2.  In vitro antioxidant and free radical scavenging activity of four Alkanna species growing in Iran.

Authors:  Iraj Salimikia; Ali Reza Yazdinezhad; Fereshteh Golfakhrabadi; Hamid Reza Monsef Esfahani
Journal:  Pharmacognosy Res       Date:  2015 Jan-Mar

3.  Antinociceptive Effects of Prim-O-Glucosylcimifugin in Inflammatory Nociception via Reducing Spinal COX-2.

Authors:  Liu-Qing Wu; Yu Li; Yuan-Yan Li; Shi-Hao Xu; Zong-Yong Yang; Zheng Lin; Jun Li
Journal:  Biomol Ther (Seoul)       Date:  2016-05-31       Impact factor: 4.634

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.